Firm plans to offer kits for research use by the beginning of 2009.

ArunA Biomedical gained a license that allows it to commercialize human mesenchymal cells (hMSC™) developed at the University of Georgia Research Foundation. These hMSCs are derived from human embryonic stem cells.

ArunA reports that it will offer the academic and industrial research communities access to a highly uniform population of human mesenchymal cells grown as adherent monolayer cultures in multiple turn-key kit formats.

“We are targeting an early first quarter 2009 launch of ArunA’s first hMSC kit,”  says William Sharp, president and CEO.

Previous articleKarolinska Institute to Test Vical’s Adjuvant with Its HIV Vaccine
Next articleAffitech and Omeros Enter Agreement to Develop Antibodies